The global oxycodone drug market is estimated to grow at a moderate CAGR during the forecast period. Oxycodoneis an opioid medication. It comes in tablet shape or liquid formation. It is used for the treatment of moderate to severe pain. Mainly, it is used orally, also it is injected through muscles, veins, rectum, vagina, and anal. Oxycodone comes under prescribed drugs. Oxycodone is similar to a group of natural substances in the brain called endorphins. These substances work to decrease the pain messages that the body sends to the brain. By mimicking these substances, oxycodone decreases the amount of pain the brain thinks. The oxycodone market is driven by an increase in the number of patients suffering from terminally ill diseases, such as cancer and HIV, and a surge in the prescription of post-operative pain medication.

Increasing numbers of Parkinson’s syndrome patients are propelling the growth of the global oxycodone market. Also, the growing demand for oxycodone drugs for pain relief for the rheumatic and cancer patients is to drive the market. To relieve the post-operation pain, oxycodone is used extensively, this factor also driving the growth of this market. Liquid intravenous and intramuscular oxycodone drugs are also used for anesthesia during the surgical operation. New oxycodone drug developments and innovation in this market are the opportunities for the future growth of the global oxycodone drug market. Also, many countries' government initiatives are to drive the market in the future. Moreover, the US FDA is encouraging the drug manufacturer to come up with less addictive oxycodone drugs.

Excessive use of oxycodone drugs may lead to an addiction, this is the main restraining factor of the global oxycodone drug market. The overdose of opioids leads to death. In 2017, in the US nearly 72,000 people died due to drug overdose, out them 49,000 people died due to opioids drug overdose. Almost 66% of the drug overdose deaths in 2017 involved an opioid. On average, 115 Americans die per day from opioid abuse. Moreover, various side effects such as nausea and vomiting, constipation, headache, dizziness, lightheadedness, drowsiness, weakness or lack of energy, dry mouth, severe itching, sweating, trouble falling or staying asleep, itching of the skin are drowning the growth of the global oxycodone drug market.

Segmentation

The global oxycodone market is segmented into applications into pain management,anesthesia, andde-addiction. Pain management accounts for the largest market portion, owing to the increasing frequency of Parkinson’s syndrome,rheumatic, and cancer patients. Doctors often prescribed oxycodone drugs for the pain relief of these patients. Oxycodone is widely used to alleviate moderate-to-severe acute pain, It is an effective analgesic for many types of pain, and is especially useful for paroxysmal spontaneous pain, steady pain, allodynia associated with postherpetic neuralgia, and it is also increasingly used in the management of cancer-related and chronic pain, oxycodone has been found to improve the quality of life of patients with many types of pain.

Global Oxycodone Drugs Market By Application, 2018 (%)

Regional Outlook

Geographically, the global oxycodone drugs market is segmented based on the region including North America, Europe, Asia-Pacific, and the Rest of the world (RoW). North America is expected to have a significant market share in the global oxycodone drugs market. Key factors that are driving the North American oxycodone drugs market are the availability of proper healthcare infrastructures and the presence of the major players offering innovative drugs in the market. Moreover, the market in Asia-Pacific region is growing considerably owing to large numbers of the patient, the presence of established generic drug market, and increasing health awareness. 

Global Oxycodone Drug Market Growth, by Region 2019-2025

Competitive Landscape

The major manufactures of the oxycodone drug include Purdue Pharma L.P, Janssen Pharmaceuticals(A Johnson & Johnson Subsidiary), Inc., Hikma Pharmaceuticals USA, Inc., Pfizer, Inc., Sanofi-Aventis S.A., Sun Pharmaceutical Industries Ltd., and others. The range of oxycodone drugs provided by these companies is Oxynorm, OxyContin, Endone, Proladone, Targin, and more. These companies are receiving approvals for new drugs that are expected to contribute to the oxycodone drug market. For instance, in November 2018, FDA approved Mallinkrodt approved its oxycodone hydrochloride tablets MNK-812. It is used for the treatment of adult patients with severe pain.